Concord, MA · Founded 2020 · Privately Held (backing)
Operator of a biopharmaceutical company intended to develop an investigational siRNA medicine for preterm preeclampsia. Comanche Biopharma is based in Concord, MA and was founded in 2020. It was valued at $210 million at its later-stage round in Oct 2025, the last priced event on record. It has raised $136 million across 2 recorded rounds; the latest was a $37.5 million early-stage round in Dec 2023.
PMV mark · valuation
$210.0M
Oct 2026
Priced at
its later-stage round
Oct 2025
Total raised
$136.1M
Last round
Early Stage VC
Dec 2023
Team — not yet on record
No current team members for Comanche Biopharma are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Comanche Biopharma with a free account
·Watch Comanche Biopharma: the Monday email on marks, rounds and moves
